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Abstract
The primary treatment of hemorrhagic shock is control of the source of bleeding as soon as
possible and fluid replacement. In controlled hemorrhagic shock (CHS) where the source of
bleeding has been occluded fluid replacement is aimed toward normalization of hemodynamic
parameters. In uncontrolled hemorrhagic shock (UCHS) in which bleeding has temporarily stopped
because of hypotension, vasoconstriction, and clot formation, fluid treatment is aimed at
restoration of radial pulse, or restoration of sensorium or obtaining a blood pressure of 80 mmHg
by aliquots of 250 ml of lactated Ringer's solution (hypotensive resuscitation). When evacuation
time is shorter than one hour (usually urban trauma) immediate evacuation to a surgical facility is
indicated after airway and breathing (A, B) have been secured ("scoop and run"). Precious time is
not wasted by introducing an intravenous line. When expected evacuation time exceeds one hour
an intravenous line is introduced and fluid treatment started before evacuation.
Crystalloid solutions and blood transfusion are the mainstays of pre-hospital and in-hospital
treatment of hemorrhagic shock. In the pre-hospital setting four types of fluid are presently
recommended: crystalloid solutions, colloid solutions, hypertonic saline and oxygen-carrying blood
substitutes. In unstable or unresponsive hemorrhagic shock surgical treatment is mandatory as
soon as possible to control the source of bleeding.
Hemorrhagic shock is defined as a condition of reduced
perfusion of vital organs leading to inadequate delivery of
oxygen and nutrients necessary for normal tissue and cel-
lular function. The understanding of the pathophysiology
of shock has made significant progress only in the late
19th and early 20th centuries. Claude Bernard suggested
that the organism attempts to maintain constancy of its
milieu interie despite external forces that attempt to disrupt
it [1].
Walter B. Cannon introduced the term homeostasis  to
describe the equilibrium maintained in the internal envi-
ronment, and is credited for the first proposal to cause
deliberate hypotension in order to reduce internal hemor-
rhage in uncontrolled hemorrhage before control of
bleeding vessels [2].
Alfred Blalock proposed in 1934 four categories of shock:
hypovolemic, vasogenic (septic), cardiogenic and neuro-
genic shock [3]. Hypovolemic shock the most common
type results from loss of circulating blood volume due to
loss of whole blood (hemorrhagic shock), plasma, inter-
stitial fluid or a combination.
In 1947 Wiggers developed an animal model of graded
controlled hemorrhagic shock by uptake of shed blood
into a reservoir to maintain a predetermined level of
hypotension [4].
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This classic model was used by G. Tom Shires in the 1960s
and 1970s to demonstrate that a large extracellular fluid
(ECF) deficit occurred in prolonged severe hemorrhagic
shock which was greater than could be attributed to vas-
cular refill alone [5]. Only the infusion of both shed
blood and lactated Ringer's solution to replace the ECF
deficit, replaced the red cell mass, plasma volume, and
ECF. Based on this data, the advocates of early aggressive
resuscitation argued that the need for increasing cardiac
output and oxygen delivery to maintain microvascular
perfusion and oxygenation, exceeds any risk of accentuat-
ing hemorrhage and therefore trauma victims in hypoten-
sive hemorrhage should receive large volumes of fluids as
early as possible.
Aggressive fluid resuscitation during the Vietnam War
with red blood cells, plasma, and crystalloid solutions
allowed patients who previously would have succumbed
to hemorrhagic shock to survive. Renal failure became a
less frequent clinical problem, vital organ function was
better sustained, but fulminant pulmonary failure termed
"DaNang lung" or "Acute Respiratory Distress Syndrome
(ARDS)" appeared as an early cause of death after severe
hemorrhage.
Additional studies by this group demonstrated that this
prolonged period of hemorrhagic hypotension was asso-
ciated with the development of microvascular injury with
marked ECF deficit which could be corrected only by the
administration of isotonic crystalloids in volumes 2 to 3
times the estimated blood loss to achieve survival. This
was the basis of the current well known dogma "3 to 1
rule" for the treatment of hemorrhagic shock, which was
adopted by the ATLS for the treatment of trauma casual-
ties [6]. It was recommended that the early treatment of
hemorrhagic shock includes primarily the control of exter-
nal bleeding and early intravenous administration of
2000 ml of crystalloids through a large bore-hole catheter.
This practice however, has recently been challenged in
clinical trials [7,8] and experimental animal models [9-
12] of uncontrolled hemorrhagic shock. It was observed
that attempting to increase blood pressure to normal by
aggressive fluid resuscitation in uncontrolled hemor-
rhagic shock resulted in increased bleeding from injured
vessels, hemodynamic decompensation, and increased
mortality, when compared to no fluid resuscitation
[8,13,14] or hypotensive resuscitation (permissive hypo-
tension) [15,16].
This fundamental dissimilarity in the hemodynamic
response between controlled hemorrhagic shock (CHS) in
which the bleeding source has been occluded, and uncon-
trolled hemorrhagic shock (UCHS) in which bleeding has
temporarily stopped because of hypotension, vasocon-
striction, and thrombus formation, constitutes the basis
for our guidelines of fluid resuscitation in civilian as well
as military trauma [17].
In CHS where the external bleeding source has been
occluded as well as in UCHS where bleeding has tempo-
rarily stopped due to hypotension, when evacuation time
is estimated to be shorter than one hour (usually urban
trauma), immediate evacuation to a surgical facility is
indicated after the airway and breathing (A, B) have been
secured ("scoop and run"). Precious time is not wasted by
introducing an intravenous line before evacuation, but
infusion can be started en route to the medical facility.
When evacuation time is expected to be longer than one
hour, an intravenous line is introduced and fluid resusci-
tation is started before evacuation.
Fluid resuscitation in CHS is aimed toward normalization
of hemodynamic parameters, in contrast to UCHS, where
hemostasis cannot be safely achieved, and early rapid
evacuation to a surgical facility is considered the most
important step of management after the airway and
breathing have been secured. If transportation means are
readily available fluid treatment can be started during
evacuation.
According to the guidelines of the Israeli Defense Forces
(IDF) fluid resuscitation of CHS is aimed toward normal-
ization of hemodynamic parameters, in contrast to UCHS
where the principles of hypotensive resuscitation are oper-
ative and treatment is started when one of the three
parameters is documented [18]:
a. Altered sensorium
b. Radial pulse cannot be palpated
c. Systolic blood pressure dropped below 80 mmHg.
Fluid treatment does not include the automatic early
administration of 2000 ml of lactated Ringer's solution as
recommended by the ATLS guidelines, but repeated aliq-
uots of 250 ml are administered with continuous moni-
toring, aiming at a systolic blood pressure of 80 mmHg,
appearance of a radial pulse, or regained consciousness. In
several studies it has been demonstrated that the progno-
sis of brain injuries is primarily dependent on cerebral
perfusion [19]. Therefore, it was recommended that in
central nervous system injuries with hemorrhagic shock
fluid treatment is aimed toward a systolic blood pressure
of 100 mmHg.
Aggressive fluid infusion to achieve normal hemody-
namic parameters is prohibited in UCHS because it mayWorld Journal of Emergency Surgery 2006, 1:14 http://www.wjes.org/content/1/1/14
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renew internal bleeding ("pop the clot"). Massive fluid
resuscitation is withheld until the time of the surgical
intervention. When the expected transportation time to
the medical facility exceeds one hour, hemodynamic eval-
uation is repeated every 15 minutes, and if systolic blood
pressure drops below 80 mmHg, radial pulse cannot be
palpated or the sensorium deteriorates, aliquots of 250 ml
of Ringer's lactate solution are infused in order to main-
tain this blood pressure.
Type of infused fluids
Infusions of crystalloid solutions and blood transfusions
are the mainstays for the pre-hospital and in-hospital
treatment of severe hemorrhagic shock. Blood is required
for repletion of oxygen-carrying capacity, but it is usually
not readily available in the prehospital settings because it
requires refrigeration and typing. In the pre-hospital set-
ting there are 4 types of fluids that are presently recom-
mended for treatment of hemorrhagic shock:
1. Crystalloids
Lactated Ringer's solution is the most widely available and
frequently used balanced salt solution for fluid resuscita-
tion in hemorrhagic shock. It is safe and inexpensive, and
it equilibrates rapidly throughout the extracellular com-
partment, restoring the extracellular fluid deficit associ-
ated with blood loss. Because of the rapid equilibration of
balanced salt solutions into the extracellular space, larger
volumes may be required for adequate resuscitation,
resulting in decreased intravascular oncotic pressure.
Although the use of crystalloids has been routine for
resuscitation of patients with acute blood loss, several
studies have raised questions regarding the effects of
resuscitation regimens on aspects of the immune response
to hemorrhagic shock. It was observed by Rhee et al. [20]
that lactated Ringer's solution exacerbated neutrophil
superoxide burst activity and increased neutrophil adher-
ence. Also, it has been shown that aggressive crystalloid
resuscitation was followed by increased cytokine activa-
tion including IL-1, IL-6, and TNF. [21]. The significant
advantage of the currently available lactated Ringer's solu-
tion is that it provides a source of bicarbonate as a result
of the metabolism of lactate to CO2 and H2O; and unlike
bicarbonate, lactated Ringer's solution does not precipi-
tate calcium when it is added to intravenous fluids.
2. Colloid solutions
The use of colloid solutions that tend to remain in the
intravascular compartment has been advocated for treat-
ment of hemorrhagic shock. Several colloid solutions
were studied in clinical practice including human albu-
min, hydroxyl ethyl starch (HES), and dextran. Because
colloid solutions remain briefly in the intravascular com-
partment, a lower total volume of resuscitative fluid is
required to attain hemodynamic stability compared to
crystalloid solutions. However, colloid solutions are more
expensive, may bind and decrease serum ionized calcium,
decrease circulating levels of immunoglobulines, and may
further compromise the extracellular fluid volume deficit
rather than restoring it. Numerous experimental and clin-
ical studies have compared crystalloid and colloid fluid
resuscitation [22,23]. There is no clinical evidence that
appropriate resuscitation with balanced salt solution is
associated with any harmful effects on pulmonary func-
tion when guided by hemodynamic parameters [24]. No
protective effect of colloid solutions on post-resuscitation
pulmonary function was demonstrated, even though col-
loid solutions do produce transiently greater intravascular
expansion per unit compared to crystalloid solutions.
Colloid solutions are recommended in military scenarios
because of a major concern with regard to resuscitation of
hemorrhage in the military setting where considerable
weight and volume of crystalloid solutions must be trans-
ported in the field sometimes on the back of the medical
professionals. This results in an inadequate bulk of the
Ringer's lactate solution that is transported to the front-
line and thus compromises the resuscitation phase in for-
ward areas of deployment. In addition, patients in
hemorrhagic shock in a combat area are frequently dehy-
drated, presenting an additional problem for successful
resuscitation.
3. Hypertonic solutions
Clinical and experimental studies have demonstrated that
a small volume of hypertonic saline (5 ml/kg NaCl 7.5%)
with or without dextran can be an effective initial resusci-
tation solution. Hypertonic solutions improve microvas-
cular flow, control intracranial pressure, stabilize arterial
pressure and cardiac output with small-volume infusion,
with no deleterious effects on immune functions [25-27].
Based on the safety and efficacy of hypertonic saline, with
the need for simplicity, limited volume that can be carried
in the field particularly in military scenarios, and the rela-
tive low cost, the Committee on Fluid Resuscitation for
Combat Casualties of the Institute of Medicine [28] con-
cluded that the initial fluid resuscitation of the hemor-
rhaging battlefield casualty should be a 250 ml bolus of
7.5% saline delivered by a rapid infusion system. Systemic
access would be achieved via an intraosseous needle or by
intravenous access. This practice, however, has been
recently challenged in clinical trials as well as laboratory
studies of UCHS. Meta-analysis of clinical studies of
hypertonic saline treatment of traumatic hemorrhagic
shock showed an increase in blood pressure and cardiac
output but there was no significant improvement in sur-
vival [24]. In animal studies hypertonic saline treatment
of UCHS secondary to large-vessel injury resulted in
increased bleeding from injured blood vessels, hemody-
namic decompensation and increased mortality [9-11]. In
UCHS secondary to solid organ injury (massive splenicWorld Journal of Emergency Surgery 2006, 1:14 http://www.wjes.org/content/1/1/14
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injury) hypertonic saline infusion improved hemody-
namics but did not increase bleeding from the injured
solid organ [12].
4. Oxygen-carrying blood substitutes
hold promise as effective resuscitation fluids that may
improve oxygen carrying capacity without problems of
storage, compatibility, and disease transmission that are
associated with standard blood transfusion. Oxygen-car-
rying blood substitutes can be generally divided into two
types: fluorocarbon-based synthetic oxygen carriers and
stroma-free cross linked human or non-human hemo-
globin products. The fluorocarbon emulsions are easy to
produce, have a long shelf life, and have minimal infec-
tious or immunogenic effects. Potential disadvantages
include the requirement of a high FiO2, and rapid plasma
clearance. Hemoglobin-based oxygen carriers are notable
for high oxygen carrying capacity, an appreciable oncotic
effect, and prolonged shelf life. Disadvantages include
short plasma half life, potential renal toxicity, hyperten-
sive effects, and the potential of immunogenic effects. Fur-
ther clinical trials to establish the optimal dosage, efficacy,
safety, and the effect on outcome are indicated before oxy-
gen-carrying blood substitutes are implemented in rou-
tine clinical practice.
Once oxygenation and circulating volume have been
restored, re-evaluation of the clinical situation is in order.
Vital signs, mental status, urinary output, and capillary
refill should be assessed regularly throughout the resusci-
tation. Initiation of central monitoring may be indicated
at this time, if the response to initial resuscitation has
been less than expected, or if blood loss is ongoing. Blood
should be drawn to assess hematological, coagulation,
electrolyte and metabolic status. Electrolyte and meta-
bolic disorders as well as coagulation deficiencies should
be corrected. Arterial blood gases should be obtained to
determine the adequacy of oxygenation. Management of
alternations in oxygenation, ventilation, pH, fluid and
electrolyte balance should now be based on clinical eval-
uation and laboratory measurement. Blood components
may also be used at this stage to replace identified defi-
ciencies.
Most cases of unresponsive hemorrhagic shock to fluid
management in the trauma patient are due to ongoing
losses of blood volume or myocardial dysfunction. While
initial stabilization is taking place, attention should be
directed to prompt arrest of bleeding. Aggressive restora-
tion of normal blood pressure without arrest of internal
hemorrhage will enhance further losses of blood volume
by increasing flow and impeding coagulation at the site of
injury. Mild to moderate hypotension allows for clot for-
mation and slows bleeding from injured blood vessels
(hypotensive resuscitation). The hemodynamically unsta-
ble injured victim should be brought to surgery as soon as
possible and the source of bleeding promptly identified
and arrested.
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